INCYTE CORPORATION Convertible Debt, Current
INCYTE CORPORATION (INCY) had Convertible Debt, Current of $11.90 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2021-02-09
- 2020-09-30: Convertible Debt, Current $11.90M.
- 2020-06-30: Convertible Debt, Current $18.59M.
- 2020-03-31: Convertible Debt, Current $18.52M.
- 2019-12-31: Convertible Debt, Current $18.30M.
| Period end | Convertible Debt, Current | Convertible Debt, Current as first filed |
|---|---|---|
| 2020-09-30 | $11.90M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $18.59M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $18.52M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $18.30M 10-K · filed 2021-02-09 | |
| 2018-09-30 | $7.65M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $7.55M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $7.46M 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $7.39M 10-K · filed 2019-02-14 | |
| 2015-09-30 | $5.00K 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $42.94M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $87.34M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $85.19M 10-K · filed 2016-02-12 | $85.64M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |